12 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 34189161 | Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae-Producing KPC-31, a D179Y Variant of KPC-3. | 2021 Jun | 1 | ||
2 | 34747363 | Ceftazidime/avibactam resistance is associated with different mechanisms in KPC-producing Klebsiella pneumoniae strains. | 2021 Nov 5 | 1 | ||
3 | 31733412 | Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature. | 2020 Sep | 1 | ||
4 | 32277821 | Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. | 2020 Jul 1 | 1 | ||
5 | 32660988 | Resistance to Ceftazidime/Avibactam plus Meropenem/Vaborbactam When Both Are Used Together Is Achieved in Four Steps in Metallo-β-Lactamase-Negative Klebsiella pneumoniae. | 2020 Sep 21 | 1 | ||
6 | 33106265 | KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam. | 2020 Dec 16 | 2 | ||
7 | 31365094 | Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo. | 2019 Nov 1 | 4 | ||
8 | 31527032 | Phenotypic, biochemical and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activity. | 2019 Sep 16 | 1 | ||
9 | 28739787 | Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity. | 2017 Oct | 1 | ||
10 | 27396948 | Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient. | 2016 Aug | 1 | ||
11 | 26169413 | Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. | 2015 Sep | 1 | ||
12 | 26195508 | First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate. | 2015 Oct | 1 |